Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for ...
Cereno Scientific , an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug ...
The Hackett Group, Inc. ("Hackett" or the "Company"), a leading generative artificial intelligence ("Gen AI") consultancy and executive advisory firm, today announced the final results of its modified ...
Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed or refractory follicular lymphoma based on first data from single-arm US cohort of phase III CELESTIMO study1Data ...
Updated Positive Data at ASH 2025 Reinforce the Potential of Incyte's INCA033989, its First-in-Class mutCALR-Targeted ...
Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback